The isoform-specific effects can differ in the distinct stages of the breast cancer disease, e.g. AKT1 could promote tumor initiation and growth of the primary tumor, whereas AKT2 preferably promotes tumor progression and metastasis [123, 127]. Here, AKT1 is linked to neoplasm.